Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy
- 1 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (1), 238-242
- https://doi.org/10.1161/hs0102.101817
Abstract
Background and Purpose— We hypothesized that different ethnic groups would have different levels of knowledge and perceptions of atrial fibrillation (AF) and of their antithrombotic therapy. To investigate this further, we conducted a cross-sectional survey of patients with documented chronic AF who were attending the anticoagulation clinic in our city center teaching hospital, serving a multiethnic population. Methods— We surveyed 119 patients (77 male; mean age 69±9 years [mean±SD]); of these, 39 were Indo-Asian (33%), 27 Afro-Caribbean (23%), and 53 white (44%). Results— Only 63% of patients in the overall study cohort were aware of their cardiac condition, with Indo-Asians and Afro-Caribbeans significantly less aware of AF compared with the white patients (P<0.001). When questioned about the perception of the severity of the underlying condition, the majority (61%) felt that AF was “not serious.” A large proportion were unaware that AF predisposed to thrombosis and stroke; among the ethnic groups, Ind...Keywords
This publication has 17 references indexed in Scilit:
- The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis Commentary: patients, preferences, and evidenceBMJ, 2000
- Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillationThe Lancet, 2000
- Why Do Patients With Atrial Fibrillation Not Receive Warfarin?Archives of Internal Medicine, 2000
- Informed Decision Making in Outpatient PracticeJAMA, 1999
- OLDER MEN'S HEALTH: Sociocultural and Ecological PerspectivesMedical Clinics of North America, 1999
- A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial FibrillationA Randomized Controlled TrialJAMA, 1999
- Sharing decisions with patients: is the information good enough?BMJ, 1999
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- The Impact of Long-term Warfarin Therapy on Quality of LifeArchives of Internal Medicine, 1991
- Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales.BMJ, 1991